Immunoassay/ELISA Kits
Immunoglobulins
ELISpot Kits
Matched Antibody Pairs
Monoclonal Antibodies
Polyclonal Antibodies
Miscellaneous
Custom Service
Product Catalog
Science Bulletin Board
Distributor Resources
Articles
In The News
|
|
 |
|
|
Patent
Status
|
|
|
The
product has completed development (Phase IV Clinical
Trials) and has been marketed in China. The product has
received official approval of production and marketing
from the State Drug Administration (SDA) of China in
2001.
|
|
|
|
|
|
In order to
market the product in North America and other areas of
the world, Anogen (YES Biotech) has been issued patents
for the methodology and technology used in manufacturing
ABCream from Europe and Canada. Anogen is also seeking
approval to begin clinical trials of ABCream in Canada. |
|
|
|
|
|
On December
12, 2006 Anogen was granted the US patent for ABCream. |
| |
|
|
|
Anogen is the
first and the only company developing a topical
anti-IL-8 monoclonal antibody treatment for
psoriasis. |
|
|
|
|
Country
|
Status
|
Date
Issued
|
Patent
No. |
|
Australia
|
Granted
|
May
4, 2001
|
727937 |
|
Canada
|
Granted
|
August
3, 2001
|
2,291,144 |
|
China
|
Granted
|
July
7, 2001
|
ZL
97 1 12184.2 |
|
Europe
|
Granted
|
June
23, 2002
|
0991423 |
|
United
States of America
|
Granted
|
December
12, 2006
|
7,147,854 |
|
|
